dual gip/glp-1 receptor agonist Mechanisms of action of GLP-1 RA and GLP-1/GIP agonists. ↑: GLP-1, glucagon, and GIP mechanisms

and the insulin receptor and plays a key role in cell cycle progression

TB-500 is a systemic recovery peptide: a synthetic fragment of Thymosin Beta-4, it circulates throughout the body to reduce inflammation, improve cell migration, and support recovery across multiple tissue types simultaneously

These substances not only induce physical dependence and psychological addiction but also contribute to severe neurotoxicity, manifesting as persistent cognitive impairment, emotional instability, and motor dysfunction

Boosts Antioxidant Levels: Supports the body's defense against oxidative stress for enhanced cellular health

In addition to JPH-203, other drugs currently in preclinical and clinical trials targeting LAT1 include IPA-131, QBS-10072S, TLX101-CDx, 124I-ACD-101, 211At-TLX-102, OKY-034, [18F] NKO-028 (Table 1)